Litcius/Paper detail

HDAC3 inhibitor RGFP966 controls bacterial growth and modulates macrophage signaling during Mycobacterium tuberculosis infection

Monica Campo, Sarah Heater, Glenna J. Peterson, Jason D. Simmons, Shawn Skerrett, Harriet Mayanja‐Kizza, Catherine M. Stein, W. Henry Boom, Thomas R. Hawn

2021Tuberculosis28 citationsDOIOpen Access PDF

Topics & Concepts

Mycobacterium tuberculosisMicrobiologyAlveolar macrophageHistone deacetylaseMacrophageBiologySecretionImmune systemMonocyteCytokineImmunologyTuberculosisMedicineHistoneBiochemistryIn vitroGenePathologyTuberculosis Research and EpidemiologyImmune cells in cancerHistone Deacetylase Inhibitors Research
HDAC3 inhibitor RGFP966 controls bacterial growth and modulates macrophage signaling during Mycobacterium tuberculosis infection | Litcius